-+ 0.00%
-+ 0.00%
-+ 0.00%

XILIO THERAPEUTICS - PLANS TO REPORT INITIAL PHASE 1 DATA FOR XTX501 IN METASTATIC NSCLC IN Q4 2027

Reuters·11/10/2026 12:30:01

Please log in to view news